Praziquantel

Routes
Oral (PO)
Half-Life (t½)
PO: 1.5h
Formula
C19H24N2O2
Molecular Weight
312.41 g/mol
PubChem CID
4891
Aliases
Biltricide

Pharmacological Mechanism

Antitrematodal / cestocidal — increases parasite Ca²⁺ permeability causing tegument paralysis + disintegration. First-line for schistosomiasis, tapeworm infections (taeniasis, cysticercosis), liver flukes. Dramatic reduction in schistosomiasis burden in endemic areas via mass drug administration.

Half-Life & Elimination Curve (PO: 1.5h)

100%50%25%12.5%0%0h0×t½1.5h1×t½3h2×t½4.5h3×t½6h4×t½7.5h5×t½0×t½ (0h): 100% remaining (~1.89 mg/L)1×t½ (1.5h): 50% remaining (~0.947 mg/L)2×t½ (3h): 25% remaining (~0.474 mg/L)3×t½ (4.5h): 12.5% remaining (~0.237 mg/L)4×t½ (6h): 6.3% remaining (~0.118 mg/L)5×t½ (7.5h): 3.1% remaining (~59.2 µg/L)
Plasma (PO)t½ Decay (1.5h)
  • 0×t½0h100% (1.89 mg/L)
  • 1×t½1.5h50% (0.947 mg/L)
  • 2×t½3h25% (0.474 mg/L)
  • 3×t½4.5h12.5% (0.237 mg/L)
  • 4×t½6h6.3% (0.118 mg/L)
  • 5×t½7.5h3.1% (59.2 µg/L)
Elimination t½1.5h (PO)
Rate Constant (ke)0.462 h⁻¹
Time to Peak (Tmax)1.13h
Est. Peak (Cmax)1.89 mg/L
Clearance (CL)277 L/h
97% Washout (5×t½)7.5h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References